The outpatient prescription market has also changed significantly as COVID-19 epidemic has been prolonged. The pharmaceutical market, which is mainly used for infectious diseases such as antibiotics, anti-septic drugs, and influenza (flu) treatments, has shrunk significantly. The flu treatment market has shrunk 99.9% in two years.

According to UBIST on the 20th, the amount of outpatient prescriptions for Cephalosporin PO in the first half of last year was ￦87.7 billion, down 20.6% year-on-year. Compared to the first half of 2019, the amount of prescriptions decreased by 33.7% over two years.

Cephalosporin is an antibiotic widely used in pneumonia, sore throat, tonsillitis and bronchitis.